换一批
换一批Serum vascular endothelial growth factor is a potential biomarker of metastatic recurrence after curative resection of hepatocellular carcinoma
摘要：
Hepatocellular carcinoma (HCC) is one of the most common malignancies in China. To date, surgery is still the best solution to it. However, metastatic recurrences after curative hepatic resections are very common. Tang et al have reported that recurrence rate within 5 years of curative hepatic resection is 61.5% [1]. As curative hepatic resection has a high tendency for metastatic recurrence, therapeutic interventions such as transarterial embolization and antiangiogenesis have been tried to further improve prognosis of HCC patients. Therefore, establishing a dependable, sensitive, easy, and economical method to predict metastatic recurrence following curative hepatic resection is of clinical urgency.
更多
作者单位：
Liver Cancer Institute & Zhongshan Hospital, Shanghai Medical University, Shanghai 200032, China
[1]
期刊：
《世界胃肠病学杂志(英文版)》2000年6卷4期 565-568页
SCIMEDLINEISTIC
关键词：
endotheliun,vascularendothelial growth factorcarcinoma,hepatocelhdarenzyme-linked immunosorbentassayliver neoplasmsliver cirrhosisimmunohistochemistry
栏目名称：
BRIEF REPORTS
发布时间：
2006-07-31
基金项目：
the Sha nghai Leading Medical Subjects Grant
国家重点基础研究发展计划(973计划)
- 翻译满意度评价：
- 提交
- 浏览：0
- 被引：42
- 下载：0
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
